These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 14662697)

  • 1. The obsession with primary angioplasty.
    Melandri G
    Circulation; 2003 Dec; 108(23):e162. PubMed ID: 14662697
    [No Abstract]   [Full Text] [Related]  

  • 2. Recombinant tissue-type plasminogen activator: current concepts and guidelines for clinical use in acute myocardial infarction. Part I.
    Becker RC; Corrao JM; Harrington R; Ball SP; Gore JM
    Am Heart J; 1991 Jan; 121(1 Pt 1):220-44. PubMed ID: 1898680
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review.
    Weaver WD; Simes RJ; Betriu A; Grines CL; Zijlstra F; Garcia E; Grinfeld L; Gibbons RJ; Ribeiro EE; DeWood MA; Ribichini F
    JAMA; 1997 Dec; 278(23):2093-8. PubMed ID: 9403425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary percutaneous coronary intervention.
    Gurewich V
    N Engl J Med; 2008 Jan; 358(4):431-2; author reply 432-3. PubMed ID: 18219753
    [No Abstract]   [Full Text] [Related]  

  • 5. Primary coronary angioplasty versus thrombolysis for acute myocardial infarction.
    Fresco C
    Lancet; 2003 Apr; 361(9365):1303; author reply 1304-5. PubMed ID: 12699989
    [No Abstract]   [Full Text] [Related]  

  • 6. Recombinant tissue-type plasminogen activator in acute myocardial infarction: role of the critical care nurse.
    Kline EM
    Heart Lung; 1987 Nov; 16(6 Pt 2):779-86. PubMed ID: 2960639
    [No Abstract]   [Full Text] [Related]  

  • 7. Do we need to intervene after thrombolysis in acute myocardial infarction?
    Sleight P
    Circulation; 1990 May; 81(5):1707-9. PubMed ID: 2110038
    [No Abstract]   [Full Text] [Related]  

  • 8. Acute myocardial infarction: the case for pre-hospital thrombolysis with or without percutaneous coronary intervention.
    Schofield PM
    Heart; 2005 Jun; 91 Suppl 3(Suppl 3):iii7-11. PubMed ID: 15919654
    [No Abstract]   [Full Text] [Related]  

  • 9. Recombinant tissue plasminogen activators (rtPA): a review.
    Gurman P; Miranda OR; Nathan A; Washington C; Rosen Y; Elman NM
    Clin Pharmacol Ther; 2015 Mar; 97(3):274-85. PubMed ID: 25670034
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of tissue plasminogen activator in the coronary care unit for acute closure after coronary angioplasty.
    Alzarka A; Haft JI; Goldstein JE
    Chest; 1990 May; 97(5):1241-2. PubMed ID: 2110053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Economic analysis of the Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT-3) study: costs of reperfusion strategies in acute myocardial infarction.
    Kaul P; Armstrong PW; Cowper PA; Eisenstein EL; Granger CB; Van de Werf F; Mark DB
    Am Heart J; 2005 Apr; 149(4):637-44. PubMed ID: 15990746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immediate angioplasty versus standard therapy with rescue angioplasty after thrombolysis in the Combined Abciximab REteplase Stent Study in Acute Myocardial Infarction (CARESS-in-AMI): an open, prospective, randomised, multicentre trial.
    Di Mario C; Dudek D; Piscione F; Mielecki W; Savonitto S; Murena E; Dimopoulos K; Manari A; Gaspardone A; Ochala A; Zmudka K; Bolognese L; Steg PG; Flather M;
    Lancet; 2008 Feb; 371(9612):559-68. PubMed ID: 18280326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of time to treatment on mortality after prehospital fibrinolysis or primary angioplasty: data from the CAPTIM randomized clinical trial.
    Steg PG; Bonnefoy E; Chabaud S; Lapostolle F; Dubien PY; Cristofini P; Leizorovicz A; Touboul P;
    Circulation; 2003 Dec; 108(23):2851-6. PubMed ID: 14623806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of the clinical efficacy of recombinant tissue-type plasminogen activator thrombolysis with primary coronary stenting in acute myocardial infarction].
    Chen B; Wang W; Zhao H; Zhao M; Hubayi ; Xu CD; Lu M
    Zhonghua Nei Ke Za Zhi; 2002 Jan; 41(1):21-3. PubMed ID: 11940291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapy of acute myocardial infarct. Thrombolytic therapy plus subsequent PTCA not a taboo any longer].
    Einecke D
    MMW Fortschr Med; 2004 Mar; 146(13):8. PubMed ID: 15219118
    [No Abstract]   [Full Text] [Related]  

  • 16. [Bolus fibrinolytic therapy in acute myocardial infarction].
    Pinelli G; Urbinati S
    Ital Heart J Suppl; 2001 Dec; 2(12):1360-2. PubMed ID: 11838360
    [No Abstract]   [Full Text] [Related]  

  • 17. Is primary angioplasty feasible or will we provide a two-tier service?
    Chatelain P; Urban P
    Heart; 1997 Oct; 78 Suppl 2(Suppl 2):15. PubMed ID: 9422965
    [No Abstract]   [Full Text] [Related]  

  • 18. When should patients with acute myocardial infarction be transferred for primary angioplasty?
    Brodie BR
    Heart; 1997 Oct; 78(4):327-8. PubMed ID: 9404242
    [No Abstract]   [Full Text] [Related]  

  • 19. Delayed coronary angioplasty after thrombolytic therapy for acute myocardial infarction.
    Little T; Lee K; Mukherjee D; Milner M; Lindsay J; Pichard AD
    Am J Cardiol; 1990 Nov; 66(17):1259-60. PubMed ID: 2122706
    [No Abstract]   [Full Text] [Related]  

  • 20. Tenecteplase in the treatment of acute myocardial infarction.
    Chandra KS; Jariwala P; Lathi P
    Indian Heart J; 2009; 61(5):437-42. PubMed ID: 20635758
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.